The global pandemic has seen a renewed appreciation for research and its potential to support the health of our community. This promise of scientific progress and clinical improvement is at the heart of our approach at the Kolling, inspiring our dedicated group of researchers. As the Kolling marks 100 years of research, we are moving to strengthen our ability to achieve ground-breaking research and improve patient outcomes. Through extensive consultation, we have developed the Kolling Institute Research Strategy which will position the institute as a centre of translational research excellence. Three research priority areas have been identified during the formation of the strategy including musculoskeletal, neuroscience and pain, and cardiovascular and renal health. By focusing on areas of strength, we will be well placed to attract increased and diversified funding, while raising the profile of the institute both nationally and internationally. Valuable collaborations will be developed, enhancing the support provided through the joint venture partners, the Northern Sydney Local Health District and the University of Sydney. In 2020 we welcomed the opportunity to reflect on the milestones achieved over the last 100 years. We expect this important new strategic direction will help the Kolling drive research progress and vital improvements in healthcare over the next 100 years.
As the chair of the Kolling Institute Governance Committee, I am tremendously proud of our team of Kolling researchers and impressed by their skill, expertise and unwaivering commitment to a healthier community. Many are world renowned in their fields, leading enthusiastic teams at the forefront of scientific progress. It is important that we support our researchers with a strong strategic framework and deliver new opportunities, access to high quality facilities and new partnerships. A key component of the new strategy is the provision of research enablers, which will be instrumental in providing collaborative opportunities, operational efficiencies and increased funding. These initiatives will be available to all Kolling researchers. Researchers are set to benefit too from unprecedented support from the joint venture partners. By harnessing the resources and services of the university and the local health district, researchers will receive targeted assistance to optimise their research outcomes. The Kolling is respected for its high quality, valuable research, a reputation earned over many decades. I’m confident the initiatives developed through this new strategic framework will strengthen the Kolling’s position as a centre for world-leading research, improving the health of the broader community.
Professor Carolyn Sue AM Executive Director of the Kolling Institute
Michael Nugent Chair of the Kolling Institute Governance Committee
Made with FlippingBook - professional solution for displaying marketing and sales documents online